Stocks
Health Care
enta
Enanta Pharmaceuticals
NASDAQ: ENTA
+0.55 (+4.35%)
13.18
USD
At close at Apr 01, 14:35 UTC
Income Statement
Revenue
66.59M
Gross Profit
66.59M
Operating Income
-110.35M
Pretax Income
-72.76M
Net Income
-104.93M
EBITDA
-94.42M
EBIT
-97.00M
Earnings Per Share
-4.95
Balance Sheet
Cash & Cash Equivalents
56.67M
Total Debt
52.62M
Net Cash
-
Net Cash Per Share
-
Equity (Book Value)
138.91M
Book Value Per Share
6.56
Working Capital
-
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.